Search - tctmd.com

Displaying 81 - 100 of 533

Sort: Relevancy | Date

Presentation TVT 2023

Use of Catheter-Directed Thrombolytic Therapy for Cardiogenic Shock from Severe Aortic Stenosis due to Transcatheter Aortic Valve Thrombosis

Presenter: Zachary Tugaoen

June 09, 2023

Presentation TVT 2023

Management Strategies and Prognosis of Patients Ineligible for Transcatheter Mitral Valve Replacement

Presenter: Santiago Garcia

June 09, 2023

Presentation TVT 2023

Clinical Journey for Patients With Aortic Regurgitation: A Retrospective Observational Study From a Multicenter Database

Presenter: Nicholas Amoroso

June 09, 2023

Presentation TVT 2023

Early TAVR failure

Presenter: Itsik Ben-Dor

June 09, 2023

Presentation TVT 2023

Valve and Brain Sparing Transcatheter Aspiration Vegetectomy in an Infected Aortic Valve Bioprosthesis

Presenter: Sankalp Patel

June 09, 2023

Presentation TVT 2023

TMVR Reaching Adolescence: The Delicate Alignment of Anatomic Challenges, Clinical Need, and Device Performance

Presenter: Juan Granada

June 09, 2023

Presentation TVT 2023

Case Series Study of Transcatheter Therapy for Pure Aortic Regurgitation: from Preclinical to Clinical Application

Presenter: Dongming Hou

June 09, 2023

Presentation TVT 2023

Alcohol Septal Ablation prior to Transcatheter Mitral Valve Replacement with both Dedicated and Balloon-Expandable Devices

Presenter: Ningyan Wong

June 09, 2023

Presentation TVT 2023

AltaValve

Presenter: Vlasis Ninios

June 09, 2023

Presentation TVT 2023

Highlife

Presenter: Thomas Waggoner

June 09, 2023

Presentation TVT 2023

Cephea

Presenter: Juan Granada

June 09, 2023

Presentation TVT 2023

First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial

Presenter: Wojciech Wojakowski

June 09, 2023

Presentation TVT 2023

M3 Trial (Encircle)

Presenter: David Daniels

June 09, 2023

Presentation TVT 2023

Fluoroscopic “Lucent Line” Deployment in SAPIEN-3 TAVR is Non-Reproducible with no Impact on Short-Term Outcomes

Presenter: Gilbert Tang

June 09, 2023

Presentation TVT 2023

Apollo Trial (Intrepid)

Presenter: Martin Leon

June 09, 2023

Presentation TVT 2023

Summit Trial (Tendyne)

Presenter: Jason Rogers

June 09, 2023

Presentation TVT 2023

The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)

Presenter: Matti Adam

June 09, 2023

Presentation TVT 2023

Feasibility of Coronary Re-access And Repeat TAVR After Sapien 3 TAVR Stratified By Implant Depth: A Ct Simulation Study

Presenter: Gilbert Tang

June 09, 2023

Presentation TVT 2023

Discussion: What Can We Treat Beyond A2P2? What Can't We Treat?

Presenter: Anita Asgar

June 09, 2023

Presentation TVT 2023

First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)

Presenter: Geraldine Ong

June 09, 2023

Advertisement

Use of Catheter-Directed Thrombolytic Therapy for Cardiogenic Shock from Severe Aortic Stenosis due to Transcatheter Aortic Valve Thrombosis

Management Strategies and Prognosis of Patients Ineligible for Transcatheter Mitral Valve Replacement

Clinical Journey for Patients With Aortic Regurgitation: A Retrospective Observational Study From a Multicenter Database

Early TAVR failure

Valve and Brain Sparing Transcatheter Aspiration Vegetectomy in an Infected Aortic Valve Bioprosthesis

TMVR Reaching Adolescence: The Delicate Alignment of Anatomic Challenges, Clinical Need, and Device Performance

Case Series Study of Transcatheter Therapy for Pure Aortic Regurgitation: from Preclinical to Clinical Application

Alcohol Septal Ablation prior to Transcatheter Mitral Valve Replacement with both Dedicated and Balloon-Expandable Devices

AltaValve

Highlife

Cephea

First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial

M3 Trial (Encircle)

Fluoroscopic “Lucent Line” Deployment in SAPIEN-3 TAVR is Non-Reproducible with no Impact on Short-Term Outcomes

Apollo Trial (Intrepid)

Summit Trial (Tendyne)

The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)

Feasibility of Coronary Re-access And Repeat TAVR After Sapien 3 TAVR Stratified By Implant Depth: A Ct Simulation Study

Discussion: What Can We Treat Beyond A2P2? What Can't We Treat?

First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content